| P50 | author | Roger S McIntyre | Q88039086 |
| P2093 | author name string | Jinju Yoon | |
| P2860 | cites work | Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study | Q46202394 |
| | Divalproex in the treatment of bipolar depression: a placebo-controlled study | Q46394405 |
| | Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial | Q46596821 |
| | Risperidone in the treatment of acute mania: double-blind, placebo-controlled study | Q46681460 |
| | Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial | Q46683979 |
| | Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study | Q46886132 |
| | Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder | Q46975571 |
| | Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: A randomized, placebo-controlled study | Q48336807 |
| | Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design | Q48910862 |
| | Verapamil for the treatment of acute mania: a double-blind, placebo-controlled trial. | Q50877463 |
| | Clinical subtypes of bipolar mixed states: validating a broader European definition in 143 cases. | Q50951201 |
| | Depression during mania. Treatment response to lithium or divalproex. | Q50978467 |
| | Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials | Q21260328 |
| | The McLean-Harvard First-Episode Mania Study: Prediction of Recovery and First Recurrence | Q22241870 |
| | Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis | Q28245879 |
| | Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study | Q28248076 |
| | Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative | Q34026000 |
| | Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen | Q34757926 |
| | Exercise and bipolar disorder: a review of neurobiological mediators. | Q37569847 |
| | Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials. | Q37642766 |
| | Bipolar disorder and metabolic syndrome: an international perspective | Q37764504 |
| | Surgical treatment of morbid obesity among patients with bipolar disorder: a research agenda | Q37863532 |
| | A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania | Q38374723 |
| | Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial | Q38500339 |
| | Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials | Q42164457 |
| | A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007). | Q42930552 |
| | A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder | Q43011129 |
| | A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states | Q43258938 |
| | Asenapine versus olanzapine in acute mania: a double-blind extension study | Q43260786 |
| | Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group | Q43507067 |
| | "Mixed hypomania" in children and adolescents: is it a pediatric bipolar phenotype with extreme diurnal variation between depression and hypomania? | Q43776101 |
| | Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania | Q43923791 |
| | Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania | Q43942949 |
| | Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety | Q44045819 |
| | Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study | Q44159999 |
| | Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial | Q44385585 |
| | Efficacy of ziprasidone in dysphoric mania: pooled analysis of two double-blind studies | Q44392516 |
| | A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 |
| | A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania | Q44684784 |
| | Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients | Q44710965 |
| | Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial | Q44915194 |
| | Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol | Q45168624 |
| | Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania | Q45168960 |
| | Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial | Q45328463 |
| | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. | Q45484599 |
| | Lithium treatment and risk of dementia. | Q45940539 |
| | Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. | Q46037763 |
| | Gender, temperament, and the clinical picture in dysphoric mixed mania: findings from a French national study (EPIMAN). | Q46116103 |
| | Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study | Q46178044 |
| P304 | page(s) | 22-36 | |
| P577 | publication date | 2012-05-01 | |
| P1433 | published in | Bipolar Disorders | Q15716681 |
| P1476 | title | Efficacy of antimanic treatments in mixed states | |
| P478 | volume | 14 Suppl 2 | |